Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings 
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase 
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle 
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid 
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation 
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase 
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks 
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth 
VANCOUVER, British Columbia, April 24, 2018 -- via NetworkWire – Sunniva Inc. ("Sunniva" or the “Company") (CSE:SNN) (OTCQX:SNNVF) announced today that it will delay its fourth quarter and year ended December 31, 2017 earnings release and the subsequent earnings call, previously scheduled for April 24, 2018 and April 25, 2018, respectively. The Company now intends to release its results on April 30, 2018, after markets close. The delay is required for the Company’s auditors to complete their final audit procedures.
The Company's executive management will discuss the results during the rescheduled conference call on Tuesday, May 1, 2018 at 11:30 am Eastern Time/8:30 am Pacific Time. To participate in the call, please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674- 8052 and entering access code 5312. The replay will be available for two weeks after the call.
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.
For more information please visit: www.sunniva.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer
Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
